🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to share our new review in Nature Reviews Drug Discovery covering ongoing efforts to therapeutically target chromatin remodelers focusing on SWI/SNF complexes. Congratulations to authors Hayden Malone and Charlie! St. Jude Graduate School of Biomedical Sciences @stjuderesearch #swisnf (1/9) nature.com/articles/s4157…

Nucleosome remodeler exclusion by histone deacetylation enforces heterochromatic silencing and epigenetic inheritance. Molecular Cell Shiv Grewal 🙌 👏 cell.com/molecular-cell…

The first outing of our BAF team. 🧬👨‍🔬Excited for our new adventures in chromatin remodeling of blood cancers. Weill Cornell Medicine Weill Department of Medicine

Fantastic new work by Anders Sejr Hansen & Co. on chromatin architecture during M-to-G1 transition. 🙌 👏

Happy to contribute to this new preprint by Elena Pugacheva, Victor V. Lobanenkov 🇺🇦 & Co. What determines differential CTCF binding, beyond DNA methylation and TF/nucleosome competition? Answer: a specific nucleosome downstream of CTCF motif. Directionality matters! biorxiv.org/content/10.110…

Very sad that I will have to cancel my talk at the Fusion Conferences Epigenetics Conference tomorrow due to travel issues. It looks like it will be a fantastic meetings with an amazing lineup of speakers and topics. See you next time hopefully. 🤞

Following the steps of my peers, I will be transitioning from X to the Bluesky 🦋 platform. I hope the rest of the scientific community follows. 🙌 Username: darkobar

🦋 for Science Starter packs for genomics, bioinformatics, #Rstats, Nextflow. Moderation lists. Feeds. Let's rebuild the old scitwitter community and keep this place nice. blog.stephenturner.us/p/bluesky-for-… 🧬🖥️🧪

After recent changes to Elon Musk’s X, Bluesky has rapidly emerged as the new online gathering place for researchers. bit.ly/40UT4u3

Huge congrats to Béguelin lab at Weill Cornell Medicine. Fantastic new work showing how PRC2 inhibition boosts T cell immunotherapies. Out now in Cancer Cell. cell.com/cancer-cell/fu…

Great morning session with Panagiotis Ntziachristos on Lymphoid Oncogenesis – Molecular Insights Into Lymphoma and CLL. #ASH2024

#ASH2024 Highly recommend this place for lunch. Also, highly recommend the company Johannes C. Hellmuth ❤️

🧬 We’re excited to introduce D&D-seq, a single-cell technology that maps DNA:Protein interactions through molecular footprinting.. Check it out here: biorxiv.org/content/10.110… #Genomics #Epigenetics

Absolutely fantastic work from magnificent Yael David lab! Incredible science and amazing out-of-the-box approach. Congrats to all the authors and highly recommend the read. 🙌

So what's happening with medical research in the US? This is the cumulative award count from the NIH for the year. Doesn't look so good. But it gets worse. 1/

I'm running the NYC half marathon on March 15 to keep raising funds for ALS research - please donate if you can! Thank you. secure.als-ny.org/goto/ChrisMason

Huge congrats to Melnick Lab on being appointed the Director of the Josep Carreras Leukemia Research Institute in Barcelona! 🙌 👏

Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality dlvr.it/TKg2CZ

Huge congratulations to my postdoc Jiali Yu 👏 who has been awarded a fellowship from the National Cancer Center. National Cancer Center She’ll be investigating how chromatin remodelers contribute to the onset and progression of blood cancers. So proud and excited for what’s ahead. 🚀